Gene · 1308
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation of BP180, BP230, and type VII collagen antibody titers in serum, blister fluid, erosion, and saliva in pemphigoid diseases. | J Dermatol | 2025 | 39916594 | PubTator, text mining | PubMed |
| Identification of deep intronic variants in junctional epidermolysis bullosa using genome sequencing and splicing assays. | NPJ Genom Med | 2025 | 39915495 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived COL17A1 promotes gemcitabine resistance and tumorigenesis in pancreatic cancer cells by interacting with ACTN4. | Discov Oncol | 2025 | 39907925 | PubTator, text mining | PubMed |
| From Pruritus to Bullae: Recognizing Furosemide-Induced Bullous Pemphigoid in an Elderly Male Patient. | Cureus | 2025 | 39897249 | PubTator, text mining | PubMed |
| The role of multiomics in revealing the mechanism of skin repair and regeneration. | Front Pharmacol | 2025 | 39896077 | PubTator, text mining | PubMed |
| Phylogenetic Signal in Primate Tooth Enamel Proteins and its Relevance for Paleoproteomics. | Genome Biol Evol | 2025 | 39834226 | PubTator, text mining | PubMed |
| Clinical characteristics of bullous pemphigoid patients of different ages and the possible mechanism. | J Dermatol | 2025 | 39821084 | PubTator, text mining | PubMed |
| C4d immunostaining facilitates differentiation of pemphigoid nodularis from prurigo nodularis. | Pathol Res Pract | 2025 | 39755047 | PubTator, text mining | PubMed |
| Improvement of immunological tests for detecting autoantibodies in patients with lamina lucida-type linear IgA bullous dermatosis. | J Dermatol Sci | 2025 | 39732612 | PubTator, text mining | PubMed |
| Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid. | An Bras Dermatol | 2025 | 39694724 | PubTator, text mining | PubMed |
| Non-Herlitz junctional epidermolysis bullosa in a Native American newborn. | J Osteopath Med | 2025 | 39636096 | PubTator, text mining | PubMed |
| Use of multivariant enzyme-linked immunosorbent assay (ELISA) in the diagnosis of autoimmune bullous disorders in a resource-limited setting: A single-center experience. | Indian J Dermatol Venereol Leprol | 2025 | 39635793 | PubTator, text mining | PubMed |
| Caviar extract inhibits skin photoaging by activating skin stem cells through NF-κB/MMPs/COL17A1 axis. | Photochem Photobiol | 2025 | 39627162 | PubTator, text mining | PubMed |
| Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid. | Int J Dermatol | 2025 | 39592443 | PubTator, text mining | PubMed |
| The "entanglement" between bullous pemphigoid and diabetes mellitus: a comprehensive review and expert recommendations. | Expert Rev Clin Immunol | 2025 | 39521622 | PubTator, text mining | PubMed |
| Eosinophil extracellular traps drive T follicular helper cell differentiation via VIRMA-dependent MAF stabilization in bullous pemphigoid. | J Allergy Clin Immunol | 2025 | 39490750 | PubTator, text mining | PubMed |
| Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid. | J Dermatol | 2025 | 39428667 | PubTator, text mining | PubMed |
| Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity. | Br J Dermatol | 2025 | 39255051 | PubTator, text mining | PubMed |
| Diagnostic challenge: Juvenile bullous pemphigoid with a negative BP180 ELISA. | Pediatr Dermatol | 2025 | 39168501 | PubTator, text mining | PubMed |
| Functional decline among bullous pemphigoid patients: A retrospective monocentric cohort study. | J Eur Acad Dermatol Venereol | 2025 | 38953405 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1308/papers?page=10